Non-TNF Biologic Beats Second Anti-TNF in Rheumatoid Arthritis

This article originally appeared here.
Share this content:
Non-TNF Biologic Beats Second Anti-TNF in Rheumatoid Arthritis
Non-TNF Biologic Beats Second Anti-TNF in Rheumatoid Arthritis

WEDNESDAY, Sept. 21, 2016 (HealthDay News) -- A non-tumor necrosis factor (TNF)-targeted biologic is more effective than a second anti-TNF drug for treatment of rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug, according to a study published in the Sept. 20 issue of the Journal of the American Medical Association.

Jacques-Eric Gottenberg, M.D., Ph.D., from the Strasbourg University Hospital in France, and colleagues randomized 300 patients with rheumatoid arthritis with persistent disease activity and an insufficient response to anti-TNF therapy to receive a non-TNF-targeted biologic agent or an anti-TNF that differed from their previous treatment. Overall, 89.7 percent of patients completed the study.

The researchers found that 69 percent of patients in the non-TNF group and 52 percent in the second anti-TNF group achieved a good or moderate European League Against Rheumatism response (odds ratio, 2.06). The non-TNF group had a lower disease activity score in 28 joints-erythrocyte sedimentation rate than in the second anti-TNF group (mean difference, −0.43). More patients in the non-TNF group showed low disease activity at weeks 24 and 52 (odds ratio, 2.09 and 2.26, respectively).

"Among patients with rheumatoid arthritis previously treated with anti-TNF drugs but with inadequate primary response, a non-TNF biologic agent was more effective in achieving a good or moderate disease activity response at 24 weeks than was the second anti-TNF medication," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease


Sign up for myCME e-newsletters


More in Home

Automated Central System Offers Time Savings for Pharmacists

Automated Central System Offers Time Savings for Pharmacists

Cart-fill process using new automated system is more efficient, frees up time for other roles

Therapeutic Horseback Riding Can Help Alleviate PTSD in Veterans

Therapeutic Horseback Riding Can Help Alleviate PTSD in ...

Study found statistically and clinically significant reduction in PTSD scores after six weeks of THR

Bariatric Surgery Linked to Discontinuing Diabetes Meds

Bariatric Surgery Linked to Discontinuing Diabetes Meds

Six-year antidiabetes treatment initiation rate also much lower after bariatric surgery

is free, fast, and customized just for you!

Already a member?

Sign In Now »